DiaSorin S.p.A. (DSRLF)
USD 106.85
(0.0%)
USD 106.85
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.84 Billion USD | -8.61% |
| 2022 | 2.02 Billion USD | -4.57% |
| 2021 | 2.11 Billion USD | 496.59% |
| 2020 | 354.98 Million USD | 47.14% |
| 2019 | 241.25 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 808.24 Million EUR | -55.24% |
| 2024 Q2 | 1.51 Billion EUR | 101.7% |
| 2023 Q4 | 1.67 Billion EUR | 47.25% |
| 2023 FY | 1.84 Billion USD | -8.61% |
| 2023 Q2 | 1.86 Billion USD | 40.7% |
| 2023 Q3 | 1.13 Billion EUR | -39.03% |
| 2023 Q1 | 1.32 Billion EUR | -34.45% |
| 2022 Q3 | 303.4 Million EUR | -83.97% |
| 2022 FY | 2.02 Billion USD | -4.57% |
| 2022 Q1 | 1.52 Billion EUR | -17.96% |
| 2022 Q2 | 1.89 Billion EUR | 23.81% |
| 2022 Q4 | 2.02 Billion USD | 566.11% |
| 2021 Q2 | 782.07 Million EUR | 1732.72% |
| 2021 FY | 2.11 Billion USD | 496.59% |
| 2021 Q3 | 1.59 Billion EUR | 103.65% |
| 2021 Q4 | 1.86 Billion EUR | 16.99% |
| 2021 Q1 | 42.67 Million EUR | -85.29% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q3 | 32.24 Million EUR | -86.93% |
| 2020 Q4 | 290.12 Million EUR | 799.71% |
| 2020 FY | 354.98 Million USD | 47.14% |
| 2020 Q2 | 246.73 Million EUR | 0.0% |
| 2019 FY | 241.25 Million USD | 0.0% |
| 2019 Q4 | 214.92 Million EUR | 2247.33% |
| 2019 Q3 | 9.15 Million EUR | -96.66% |
| 2019 Q2 | 273.86 Million EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2018 Q4 | 230.5 Million EUR | 1501.24% |
| 2018 Q3 | 14.39 Million EUR | -95.69% |
| 2018 Q2 | 334.06 Million EUR | 7229.51% |
| 2018 Q1 | 4.55 Million EUR | -98.14% |
| 2017 Q4 | 244.47 Million EUR | 4824.96% |
| 2017 Q2 | 206.4 Million EUR | 229.58% |
| 2017 Q1 | 62.62 Million EUR | -71.01% |
| 2017 Q3 | 4.96 Million EUR | -97.6% |
| 2016 Q2 | 212.46 Million EUR | 112.27% |
| 2016 Q1 | 100.09 Million EUR | 11.79% |
| 2016 Q3 | 221.62 Million EUR | 4.32% |
| 2016 Q4 | 216.01 Million EUR | -2.53% |
| 2015 Q1 | 138.87 Million EUR | -6.05% |
| 2015 Q4 | 89.53 Million EUR | 2.96% |
| 2015 Q3 | 86.96 Million EUR | -32.95% |
| 2015 Q2 | 129.69 Million EUR | -6.61% |
| 2014 Q1 | 167.49 Million EUR | 8.13% |
| 2014 Q2 | 151.96 Million EUR | -9.27% |
| 2014 Q3 | 146.95 Million EUR | -3.29% |
| 2014 Q4 | 147.81 Million EUR | 0.58% |
| 2013 Q2 | 148.56 Million EUR | -6.49% |
| 2013 Q3 | 153.11 Million EUR | 3.07% |
| 2013 Q1 | 158.86 Million EUR | 0.0% |
| 2013 Q4 | 154.9 Million EUR | 1.16% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | -51093.927% |
| Arrayit Corporation | 7.49 Million USD | -24538.884% |
| Atlantic International Corp. | 3.82 Million USD | -48143.959% |
| Biocept, Inc. | 22.01 Million USD | -8290.846% |
| Bioqual, Inc. | 18.93 Million USD | -9653.289% |
| CardioGenics Holdings Inc | 1.79 Million USD | -102805.633% |
| DermTech, Inc. | 64.75 Million USD | -2752.408% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | -151.312% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | -14812.669% |
| iMD Companies, Inc. | 1.67 Million USD | -110224.885% |
| IDenta Corp. | 1.01 Million USD | -182208.868% |
| Interpace Biosciences, Inc. | 28.15 Million USD | -6459.921% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | -619834.714% |
| InVitro International | 78.99 Thousand USD | -2338267.997% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | -9262.243% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -1428453.548% |
| Medical Imaging Corp. | 9.51 Million USD | -19308.009% |
| NovelStem International Corp. | 4.2 Million USD | -43814.46% |
| Optigenex Inc. | 9.57 Million USD | -19199.451% |
| PharmChem, Inc. | 558.64 Thousand USD | -330533.993% |
| Proteome Sciences plc | 18.48 Million USD | -9890.111% |
| Response Genetics, Inc | 15.86 Million USD | -11540.996% |
| Rennova Health, Inc. | 49.66 Million USD | -3618.896% |
| RushNet, Inc. | 6.23 Million USD | -29505.373% |
| ScreenPro Security Inc. | 1.6 Million USD | -115299.968% |
| Stella Diagnostics Inc. | 18 Million USD | -10158.458% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | -22414.375% |
| Todos Medical Ltd. | 50.15 Million USD | -3582.59% |